CYH 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围

03
价格 $2.72
市值 (MRQ) $384M
P/E (TTM) 1.5
EPS (TTM) $1.86
收入 (TTM) $11.98B
ROE (TTM) -16.7%
负债/权益 (MRQ) -6.9
52周区间 $2–$4

CYH 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图

04
区间
条形图

柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。

股票拆分 1
除息日 拆股 类型
2016年4月22日 121-for-100 正向

关于 Community Health Systems, Inc. Common Stock 公司概况(来自维基百科)

05 · wikidata

Community Health Systems, Inc. (CHS) is a Fortune 500 company based in Franklin, Tennessee. It was the largest provider of general hospital healthcare services in the United States in terms of number of acute care facilities. In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.

In August 2015, the company announced plans to spin off 38 hospitals and its management and consulting subsidiary, Quorum Health Resources, into a new publicly traded company called Quorum Health Corporation. The company completed the spinoff of Quorum Health Corporation on April 29, 2016. Quorum owns or leases hospitals across 16 states, primarily in cities or counties with populations of 50,000 or less. In April 2020 Quorum declared bankruptcy and is no longer trading on the NYSE.

On October 3, 2016, CHS was removed from the S&P Midcap 400 and added to the S&P Smallcap 600. Under CEO Wayne T. Smith, the company's stock has lost over 76% of its value since the year 2000.

Chinese billionaire Tianqiao Chen had a 22.2 percent stake in Community Health Systems in 2017.

History

Founding and early years (1985–2014)

E. Thomas Chaney, former executive of Hospital Affiliates, Inc. and David Steffy and Richard Ragsdale, former executives at Hospital Corporation of America spinoff Republic Health Corporation, formed Community Health Systems in 1985.

The company made its initial public offering in 1991. In 1996, the company was purchased by private equity firm Forstmann Little & Company. Community Health Systems went public again in 2000. In August 2003, the company acquired Southside Regional Medical Center. On October 10, 2015, the 372-bed Grandview Medical Center began operating in Birmingham, Alabama, replacing Trinity Medical Center.

In 2000, Community Health Systems paid $31 million to the United States Department of Justice to settle a review of its billing practices.

In 2007, Community Health Systems purchased Plano, Texas-based Triad Hospitals for $6.8 billion, adding nearly 50 hospitals, hospital management and consulting business Quorum Health Resources, and nearly doubling the size of the company. Among the facilities included in the deal was McKenzie-Willamette Hospital in Springfield, Oregon; Trinity Medical Center in Birmingham, Alabama; and the seven hospitals of Lutheran Health Network in the Ft. Wayne, Indiana region.

In 2010, McKenzie-Willamette's healthcare workers' union, SEIU, Local 49, claimed that workload increases, slashed benefits, and staff reductions had lowered the quality of both patient care and quality of life for employees. The union, in its "Profits Before Community" campaign against the hospital, continues to highlight that profits have tripled while charitable care and employee benefits have steadily decreased since the hospital moved from a non-profit to a for-profit enterprise under CHS.

In 2011, it was accused by Tenet Healthcare of overbilling Medicare in its aggressive admissions policy compared to its peers. It was subpoenaed by Medicare on its aggressive billing to the Medicare systems.

In 2013, Community Health Systems entered into an agreement with Health Management Associates to purchase HMA for about $3.6 billion in cash and stock. The merger was completed in January 2014 and made Community Health Systems the largest for-profit hospital operator at the time, with 206 hospitals in 29 states. The acquisition of HMA brought with it liability for lawsuits and criminal charges of fraudulent claims against Medicare and other federal programs. CHS settled these claims for $262 million in October, 2018.

On August 4, 2014, Community Health Systems paid $95.14 million to the United States Department of Justice to resolve multiple lawsuits "alleging that the company knowingly billed government health care programs for inpatient services that should have been billed as outpatient or observation services". As part of the agreement, Community Health Systems was required to enter into a corporate integrity agreement that required the company to participate in compliance efforts.

It was reported on August 18, 2014, that hackers broke into Community Health System's records system and stole data on 4.5 million patients. These data included names, Social Security numbers, physical addresses, birthdays and telephone numbers. CHS provided all patients whose records were impacted with free identity theft protection.

Recent developments (2015–present)

On February 2, 2015, Community Health Systems was required to pay $75 million to settle allegations "that they made illegal donations to county governments to reap more federal dollars under a now-discontinued matching program". The allegations were brought about by a former CHS employee in a complaint under the False Claims Act.

In October 2015, Community Health Systems paid $13 million to the United States Department of Justice to resolve allegations related to the False Claims Act.

After CHS agreed in 2015 to sell Memorial Hospital of Salem County in New Jersey to Prime Healthcare Foundation, a nonprofit affiliated with Prime Healthcare Services; the sale was approved by New Jersey in early February 2017.

On December 6, 2016, a former CFO of a CHS hospital was awarded $1.9 million in a whistleblower lawsuit he filed after he was terminated for refusing to submit false financial documents.

In January 2017, a settlement between investors and CHS executives for $60 million was reached. The settlement resolved allegations of "breach of fiduciary duty" by CHS executives.

In March 2017, Quorum's board retained outside counsel in relation to whether Community Health Systems had committed fraud with regards to financial projections for Quorum, and whether any of its current management may have been involved in any possible fraud. In June 2017 Quorum said although the investigation did not produce "conclusive evidence" of fraud the projections appeared to be incompetent at best.

In April–July 2017, Community Health Systems rejected overtures from key Lutheran Health Network doctors to facilitate sale of its profitable network in CHS to a third party, after assertions of continual lack of re-investment into the network's facilities and staff by CHS management. After those discussions/accusations became public, several key leaders of the affiliated hospitals, Lutheran and Dupont, and the network were fired or resigned. Key prominent local community leaders Chuck Surack and Tom Kelley resigned from the Lutheran Health Network's and hospitals' advisory boards.

On March 13, 2018, it was reported that the company had hired financial advisory firm Lazard to help address long-term debt.

On August 1, 2018, CHS completed the sale of 425-bed Munroe Regional Medical Center in Ocala, Fla., to Altamonte Springs, Fla.-based Adventist Health System.

On May 22, 2019, AdventHealth announced they had signed definitive agreements to purchase 193-bed Heart of Florida Regional Medical Center in Davenport, Florida, and 160-bed Lake Wales Medical Center in Lake Wales, Florida, from affiliates of CHS.

In December 2019, CHS announced that subsidiaries of the company have completed the sale of three Virginia hospitals – Southside Regional Medical Center in Petersburg, Southampton Memorial Hospital in Franklin, and Southern Virginia Regional Medical Center in Emporia, effective on January 1, 2020.

On April 27, 2020, CHS announced that an affiliate of the company has signed a definitive agreement to sell its majority ownership interest in 84‑bed St. Cloud Regional Medical Center and its associated healthcare operations in St. Cloud, Florida, to a subsidiary of Orlando Health. Orlando Health currently holds minority ownership interest in St. Cloud and will purchase the remaining interest through this transaction.

On September 30, 2020, CHS announced that an affiliate of the company has completed the sale of 480-bed Bayfront Health St. Petersburg and its associated assets to a subsidiary of Orlando Health.

In its annual Form 10-K filed in 2019, it identified Florida, Texas and Indiana as areas of geographic concentration.

In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.

From March 2020 to May 2021, during the COVID-19 pandemic, CHS filed more than 19,000 lawsuits against individuals for not being able to pay off their medical debt (some from hospitals it no longer owned) even as the company collected over $700 million in Covid relief funds from the federal government. Many of these lawsuits were against people who could not pay the legal fees to challenge CHS in court. (Due to the fact that these are civil suits and not criminal suits, the defendants do not receive a state-appointed lawyer.) In 2020, CHS posted its most profitable year in at least a decade.

Predatory liens practices

Lawsuits have been filed against CHS hospitals for alleged predatory liens practices where hospitals file for liens rather than bill individuals' health insurers, resulting in massive fees for patients.

来源:维基百科 (英语), CC BY-SA 4.0 · 在维基百科上查看 ↗

Wikidata ↗

行业板块Health Care 行业Health Care 员工44000 国家US

10年表现 收入、净利润、利润率和每股收益趋势

06
收入$12.48B
2016-12-31 → 2025-12-31
EPS$3.77
2016-12-31 → 2025-12-31
自由现金流$208M
2016-12-31 → 2025-12-31
净利率2.1%
2018-12-31 → 2025-12-31
估值与比率 07–12

估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜?

指标 5年趋势 CYH 5年均值 同行中位数 结论
P/E (TTM) 1.55年均值 ≈3.4 ≈3.4 15.5 低估
P/S (TTM) 0.05年均值 ≈0.1 ≈0.1 1.2 低估
市净率 (MRQ) -0.35年均值 ≈-0.5 ≈-0.5 · ·
EV / EBITDA (企业价值 / EBITDA) 7.15年均值 ≈13.1 ≈13.1 10.6 低估
股价/自由现金流 (TTM) -2.15年均值 ≈-0.8 ≈-0.8 · ·
市现率 (TTM) 3.05年均值 ≈-1.6 ≈-1.6 6.5 低估
EV / Revenue (市值/营收) 0.85年均值 ≈1.0 ≈1.0 · ·
EV / FCF (市值/自由现金流) 50.55年均值 ≈-4.9 ≈-4.9 · ·

同行中位数按每项指标的标准化基础计算,可能与本股票显示的TTM/MRQ基础不完全匹配。

价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判

股息 收益率、派息率、股息历史、5年CAGR

13
除息日金额货币收益率
十二月 13, 2012$0.21USD≈0.84%

收益历史 每股收益实际值 vs 预估值,惊喜%,达标率,下次财报日期

14
平均惊喜 37.9%
下次报告 十月 21, 2026
期间报告EPS ActualEPS 预期惊喜
2026年6月30日 七月 21, 2026 $-0.19 $-0.06 -201.1%
2026年3月31日 $-0.48 $-0.10 -387.3%
2025年12月31日 $-0.01 $-0.10 90.5%
2025年9月30日 $1.27 $-0.25 610.5%
2025年6月30日 $-0.05 $-0.11 52.6%
2025年3月31日 $-0.03 $-0.08 62.6%

完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表

15
损益表 13
指标 趋势 2025202420232022202120202019201820172016
Revenue $12.48B$12.63B$12.49B$12.21B$12.37B$11.79B$13.21B$14.15B$15.35B$18.44B
Cost of Revenue $1.86B$1.95B$1.99B$1.98B$2.04B$1.96B$2.15B$2.35B$2.67B$3.01B
Operating Expenses $11.00B$12.09B$11.53B$11.39B$10.97B$10.66B$12.56B$13.95B$17.23B$19.30B
Operating Income $1.49B$542M$957M$821M$1.40B$1.13B$650M$208M$-1.88B$-860M
Interest Income $2M$3M$2M$2M$3M$3M$3M$7M$11M$14M
Pretax Income $724M$-283M$207M$349M$499M$422M$-430M$-715M$-2.83B$-1.72B
Income Tax $48M$79M$191M$170M$131M$-185M$160M$-11M$-449M$-104M
Net Income $509M$-516M$-133M$46M$230M$511M$-675M$-788M$-2.46B$-1.72B
EPS (Basic) $3.81$-3.90$-1.02$0.35$1.82$4.43$-5.93$-6.99$-22.00$-15.54
EPS (Diluted) $3.77$-3.90$-1.02$0.35$1.76$4.39$-5.93$-6.99$-22.00$-15.54
Shares (Basic) 133,564,227132,101,768130,445,677128,808,387126,754,852115,491,022113,739,046112,728,274111,769,821110,730,971
Shares (Diluted) 135,012,240132,101,768130,445,677130,060,319130,597,410116,544,561113,739,046112,728,274111,769,821110,730,971
EBITDA $1.49B$542M$957M$821M$1.40B$1.13B$1.26B$908M$-1.02B$240M
资产负债表 26
指标 趋势 2025202420232022202120202019201820172016
Cash & Equivalents $260M$37M$38M$118M$507M$1.68B$216M$196M$563M$238M
Receivables $2.08B$2.29B$2.23B$2.04B$2.06B$1.93B$2.26B$2.35B$2.38B$3.18B
Other Current Assets $381M$358M$275M$235M$269M$338M$358M$400M$462M$568M
Current Assets $3.23B$3.30B$3.21B$3.08B$3.48B$4.51B$3.43B$3.55B$4.07B$4.67B
PP&E (Net) $4.50B$4.78B$5.21B$5.37B$5.55B$5.32B$5.61B$6.14B$7.05B$8.15B
PP&E (Gross) $8.91B$9.16B$9.51B$9.64B$9.76B$9.35B$9.65B$10.30B$11.50B$12.42B
Accum. Depreciation $4.41B$4.38B$4.30B$4.27B$4.20B$4.03B$4.04B$4.16B$4.45B$4.27B
Goodwill $3.32B$3.79B$3.96B$4.17B$4.22B$4.22B$4.33B$4.56B$4.72B$6.52B
Intangibles $7M$15M$20M$2M····$10M$14M
Other Non-current Assets $2.10B$2.17B$2.05B$2.01B$1.91B$1.90B$2.21B$1.54B$1.54B$2.59B
Total Assets $13.20B$14.05B$14.46B$14.67B$15.22B$16.01B$15.61B$15.86B$17.45B$21.94B
Accounts Payable $842M$913M$912M$773M$830M$783M$811M$887M$967M$995M
Accrued Liabilities ······$1.13B$1.09B$1.13B$1.23B
Current Liabilities $2.21B$2.35B$2.14B$2.19B$2.36B$2.81B$2.28B$2.39B$2.36B$2.89B
Capital Leases $537M$535M$563M$605M$535M$524M$487M$84M$287M$302M
Deferred Tax $25M$231M$369M$354M$192M$29M$200M$26M$19M$411M
Other Non-current Liabilities $891M$828M$739M$644M$827M$1.60B$894M$1.01B$1.36B$1.57B
Total Liabilities $14.04B$15.37B$15.28B$15.40B$16.03B$17.06B$17.25B$16.82B$17.61B$19.66B
Long-term Debt $10.40B$11.45B$11.49B$11.63B$12.14B$12.22B$13.40B$13.60B$13.91B$15.24B
Total Debt $10.38B$11.43B$11.47B$11.61B$12.11B$12.09B$13.38B···
Common Stock $1M$1M$1M$1M$1M$1M$1M$1M$1M$1M
Retained Earnings $-3.57B$-4.08B$-3.56B$-3.43B$-3.48B$-3.71B$-4.22B$-3.54B$-2.76B$-299M
AOCI $-9M$-10M$-14M$-21M$-14M$-13M$-9M$-10M$-21M$-62M
Stockholders' Equity $-1.39B$-1.91B$-1.39B$-1.37B$-1.37B$-1.62B$-2.22B$-1.53B$-767M$1.61B
Liabilities + Equity $13.20B$14.05B$14.46B$14.67B$15.22B$16.01B$15.61B$15.86B$17.45B$21.94B
Shares Outstanding 138,626,917138,919,641136,774,911134,703,717132,146,282129,612,117117,822,631116,248,376114,651,004113,876,580
现金流 13
指标 趋势 2025202420232022202120202019201820172016
D&A $426M$486M$505M$534M$540M$558M$608M$700M$861M$1.10B
Stock-based Comp $11M$17M$22M$20M$25M$13M$10M$13M$24M$46M
Deferred Tax $-243M$-116M$35M$165M$171M$-187M$203M$-3M$-454M$-116M
Restructuring ····$3M·····
Other Non-cash ······$239M$352M$2.80B$1.83B
Operating Cash Flow $543M$480M$210M$300M$-131M$2.18B$385M$274M$773M$1.14B
CapEx $335M$360M$467M$415M$469M$440M$438M$527M$564M$744M
Investing Cash Flow $847M$-275M$-26M$-259M$-524M$177M$-2M$-245M$1.07B$630M
Net Debt Issued $-6.52B$-5.06B$-4.32B$-2.36B$-4.43B$-5.49B$-3.56B$-2.03B$-5.39B$-6.71B
Financing Cash Flow $-1.17B$-206M$-264M$-430M$-514M$-895M$-363M$-396M$-1.52B$-1.71B
Net Change in Cash $223M$-1M$-80M$-389M$-1.17B$1.46B$20M$-367M$325M$54M
Taxes Paid $249M$171M$91M$-6M$-4M$-2M$3M$19M$-4M$16M
Free Cash Flow $208M$120M$-257M$-115M$-600M$1.74B$-53M$-253M$209M$393M
盈利能力 7
指标 趋势 2025202420232022202120202019201820172016
Operating Margin 11.9%4.3%7.7%6.7%11.3%9.6%4.9%1.5%··
Net Margin 4.1%-4.1%-1.1%0.38%1.9%4.3%-5.1%-5.6%··
Pretax Margin 5.8%-2.2%1.7%2.9%4.0%3.6%-3.3%-5.1%··
EBITDA Margin 11.9%4.3%7.7%6.7%11.3%9.6%9.5%6.4%··
ROA 3.7%-3.6%-0.91%0.31%1.5%3.2%-4.3%-4.7%-12.5%-7.1%
ROE -30.8%31.2%9.6%-3.4%-15.3%-26.6%36.0%68.5%-580.0%-61.1%
ROIC 15.5%7.3%0.73%4.1%9.6%15.5%8.0%-13.3%206.0%-50.0%
流动性与偿付能力 4
指标 趋势 2025202420232022202120202019201820172016
Current Ratio 1.51.41.51.41.51.61.51.51.71.6
Quick Ratio 1.11.01.11.01.11.31.11.11.31.2
Debt / Equity -7.4-6.0-8.2-8.5-8.8-7.4-6.0···
LT Debt / Equity -7.4-6.0-8.2-8.5-8.8-7.4-6.0···
效率 2
指标 趋势 2025202420232022202120202019201820172016
Asset Turnover 0.90.90.90.80.80.70.80.8··
Receivables Turnover 5.75.65.86.06.25.65.76.0··
每股 5
指标 趋势 2025202420232022202120202019201820172016
Book Value / Share $-10.06$-13.78$-10.18$-10.15$-10.38$-12.54$-18.82$-13.20$-6.69$14.18
Revenue / Share $92.47$95.64$95.75$93.89$94.70$101.15$116.14$125.57··
Cash Flow / Share $4.02$3.63$1.61$2.31$-1.00$18.69$3.38$2.43$6.92$10.27
Cash / Share $1.88$0.27$0.28$0.88$3.84$12.93$1.83$1.69$4.91$2.09
EPS (TTM) $3.77$-3.90$-1.02$0.35$1.76$4.39$-5.93$-6.99$-22.00$-15.54
增长率 9
指标 趋势 2025202420232022202120202019201820172016
Revenue YoY -1.2%1.1%2.3%-1.3%4.9%·····
Revenue CAGR 3Y 0.74%0.71%1.9%·······
Revenue CAGR 5Y 1.1%·········
EPS YoY ···-80.1%-59.9%·····
EPS CAGR 3Y 120.8%·········
EPS CAGR 5Y -3.0%·········
Net Income YoY ···-80.0%-55.0%·····
Net Income CAGR 3Y 122.8%·········
Net Income CAGR 5Y -0.08%·········
估值 (TTM) 13
指标 趋势 2025202420232022202120202019201820172016
Revenue TTM $12.48B$12.63B$12.49B$12.21B$12.37B$11.79B$13.21B$14.15B$15.35B$18.44B
Net Income TTM $509M$-516M$-133M$46M$230M$511M$-675M$-788M$-2.46B$-1.72B
Market Cap $433M$415M$428M$582M$1.76B$963M$342M$328M$488M$637M
Enterprise Value $10.55B$11.81B$11.86B$12.08B$13.36B$11.38B$13.51B···
P/E 0.8-0.8-3.112.37.61.7-0.5-0.4-0.2-0.4
P/S 0.00.00.00.00.10.10.00.00.00.0
P/B -0.3-0.2-0.3-0.4-1.3-0.6-0.2-0.2-0.60.4
P / Cash Flow 0.80.92.01.9-13.40.40.91.20.60.6
P / FCF 2.13.5-1.7-5.1-2.90.6-6.4-1.32.31.6
EV / EBITDA 7.121.812.414.79.510.110.7···
EV / FCF 50.798.4-46.1-105.0-22.36.5-254.9···
EV / Revenue 0.80.90.91.01.11.01.0···
Earnings Yield 120.8%-130.4%-32.6%8.1%13.2%59.1%-204.5%-247.9%-516.4%-278.0%

最近期在左侧 · 空值显示为 ·

财务报表 损益表、资产负债表、现金流量表 — 年度,近5年

16
指标 2025-12-312024-12-312023-12-312022-12-312021-12-31
收入 $12.48B $12.63B $12.49B $12.21B $12.37B
营业利润率 % 11.9% 4.3% 7.7% 6.7% 11.3%
净收入 $509M $-516M $-133M $46M $230M
稀释后每股收益 (EPS) $3.77 $-3.90 $-1.02 $0.35 $1.76

机构持有人 (13F) 196 家申报者 · $415.1M 总计 · 截至 2026年9月30日

17

在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸;单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存,而非方向性判断。

持有人 196
持有价值 $415.1M
新仓位 31
已退出持仓 24
机构活动 — Q2 2026 与上一季度对比
新仓位 已退出持仓 增加 减少 净股数变动
31 (+9 与上一季度对比) 24 (+4 与上一季度对比) 69 (+6 与上一季度对比) 54 (-9 与上一季度对比) +7.0M

与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天,外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过,优先显示最近一个已完整报告的季度对。

机构 价值 股份 % 已追踪的13F 类型
CastleKnight Management LP $44704517 13384586 10.77% 股份
Apollo Management Holdings, L.P. $39610817 11859526 9.54% 股份
BlackRock, Inc. $36507995 10930538 8.79% 股份
VANGUARD GROUP INC $28605579 9168455 6.89% 股份
Eversept Partners, LP $26267680 7864575 6.33% 股份
NOMURA HOLDINGS INC $22388384 6703109 5.39% 股份
VANGUARD CAPITAL MANAGEMENT LLC $17668370 5289931 4.26% 股份
WHITEBOX ADVISORS LLC $12467362 3732743 3.00% 股份
GEODE CAPITAL MANAGEMENT, LLC $10582352 3167702 2.55% 股份
STATE STREET CORP $10226622 3061863 2.46% 股份
VANGUARD PORTFOLIO MANAGEMENT LLC $10082117 3018598 2.43% 股份
Saba Capital Management, L.P. $9626444 2882169 2.32% 股份
Owl Creek Asset Management, L.P. $8452277 2530622 2.04% 股份
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $8176380 2448018 1.97% 股份
DIMENSIONAL FUND ADVISORS LP $7854253 2351460 1.89% 股份
D. E. Shaw & Co., Inc. $7829388 2344128 1.89% 股份
AQR CAPITAL MANAGEMENT LLC $7651362 2290827 1.84% 股份
TWO SIGMA INVESTMENTS, LP $7365822 2205336 1.77% 股份
Diameter Capital Partners LP $6138793 1837962 1.48% 股份
BANK OF AMERICA CORP /DE/ $5903847 1767619 1.42% 股份
GOLDMAN SACHS GROUP INC $5868073 1756908 1.41% 股份
TWO SIGMA ADVISERS, LP $5816476 1864255 1.40% 股份
CARRONADE CAPITAL MANAGEMENT, LP $5230000 1565847 1.26% 股份
Allianz Asset Management GmbH $5167919 1547281 1.24% 股份
MORGAN STANLEY $4800489 1437272 1.16% 股份
NORTHERN TRUST CORP $4681414 1401621 1.13% 股份
Silver Rock Financial LP $3674000 1100000 0.89% 股份
CITADEL ADVISORS LLC $3475360 1040527 0.84% 股份
Assenagon Asset Management S.A. $2788275 834813 0.67% 股份
VANGUARD FIDUCIARY TRUST CO $2642231 791087 0.64% 股份
Jefferies Financial Group Inc. $2481286 742900 0.60% 股份
Alta Fundamental Advisers LLC $2161411 647129 0.52% 股份
Bank of New York Mellon Corp $2122084 635354 0.51% 股份
MARSHALL WACE, LLP $1906575 570831 0.46% 股份
MILLENNIUM MANAGEMENT LLC $1701580 509455 0.41% 股份
ExodusPoint Capital Management, LP $1664603 498384 0.40% 股份
READYSTATE ASSET MANAGEMENT LP $1657729 496326 0.40% 股份
WOLVERINE ASSET MANAGEMENT LLC $1339674 401100 0.32% 买入期权
Helix Partners Management LP $1336000 400000 0.32% 股份
Susquehanna Portfolio Strategies, LLC $1280940 383515 0.31% 股份
Voleon Capital Management LP $1247032 373363 0.30% 股份
Invesco Ltd. $1076599 322335 0.26% 股份
TUDOR INVESTMENT CORP ET AL $999388 299218 0.24% 股份
Pathstone Holdings, LLC $895621 268150 0.22% 股份
Prescott Group Capital Management, L.L.C. $863076 258406 0.21% 股份
UBS Group AG $851089 254817 0.21% 股份
MILLENNIUM MANAGEMENT LLC $835000 250000 0.20% 卖出期权
FEDERATED HERMES, INC. $812599 243293 0.20% 股份
LPL Financial LLC $737239 220730 0.18% 股份
IEQ CAPITAL, LLC $657963 196995 0.16% 股份

显示全部 196 个机构持有人 →

激进投资者及 5%+ 股东 1 持仓

18

提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权,意图影响发行人(激进股东持股、董事会活动、并购)。每一行显示该申报人持仓的最新已知状态。

申报人 已申报 持股 状态 目的 申报
Tianqiao Chen, Shanda Media Limited, Shanda Global Investment Limited, Shanda Global Capital Limited, Shanda Asset Management Holdings Limited ×10 申报 2021年3月11日 · 初始申报 · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

公司内部人士 56 位内幕人士 · 29 位高管 · 23 位董事

19
内部人士 角色 上次活动 持股数量 买入 12个月 卖出 12个月 净额 12个月
Kevin J Hammons CEO 2026年3月1日 A 895545 0 0 $0
Tim Hingtgen CEO 2025年3月1日 A 1388781 0 0 $0
Jason K Johnson EVP & CFO 2026年3月1日 A 268439 0 0 $0
Thomas J Aaron EVP and CFO 2019年12月7日 F 241515 0 0 $0
Larry W Cash President and CFO 2017年3月1日 A 568152 0 0 $0
Miguel S Benet President and CMO 2025年3月1日 D 47635 0 0 $0
Austen D Mason Regional President 2025年3月1日 A 142500 0 0 $0
Mark B Medley Regional President 2025年3月1日 A 128637 0 0 $0
Chad A Campbell Regional President 2025年3月1日 A 136815 0 0 $0
Charles J Cova Regional President 2024年3月1日 A 58701 0 0 $0
Lynn T Simon President and CMO 2024年3月1日 A 482657 0 0 $0
Beryl Ramsey Division President 2019年3月1日 A 62969 0 0 $0
Patton Paul Smith Division President 2019年3月1日 F 119017 0 0 $0
Iii John W Mcclellan Division President 2017年3月1日 A 41242 0 0 $0
Robert O Horrar Division President 2017年3月1日 A 68649 0 0 $0
Martin Bonick Division President 2017年3月1日 A 100458 0 0 $0
Michael T Portacci Division President 2017年3月1日 A 110156 0 0 $0
Thomas Daniel Miller Division President 2016年3月1日 A 112107 0 0 $0
David Lewis Miller President and COO 2016年3月1日 A 440840 0 0 $0
William S Hussey Division President 2015年10月28日 M 121568 0 0 $0
Martin Dewayne Smith Division President 2015年6月3日 M 94111 0 0 $0
Gary D Newsome Division President - Group Ops 2008年8月25日 M 118286 0 0 $0
David V. Rice EVP-Clinical Operations & CMO 2026年6月1日 A 30000 0 0 $0
Phillip A. Posey SVP & CAO 2026年3月1日 A 51736 0 0 $0
Justin D Pitt Pres,Chief Legal&Admin Officer 2026年3月1日 A 287750 0 0 $0
Kevin A Stockton EVP, Operations & Development 2026年3月1日 A 208290 0 0 $0
Rachel A Seifert Executive VP and Secretary 2017年3月1日 F 243065 0 0 $0
Mark T Buford SVP/Chief Accounting Officer 2012年2月25日 F 78379 0 0 $0
Martin G Schweinhart Senior Vice President 2006年3月1日 A 40354 0 0 $0
William Norris Jennings 董事 2026年8月25日 S 38468 0 1 $-118400
Ranga K Krishnan 董事 2026年6月30日 M 170023 0 0 $0
Fawn D Lopez 董事 2026年3月1日 A · 0 0 $0
Ronald L Burgess JR 董事 2026年3月1日 A · 0 0 $0
Susan W Brooks 董事 2026年3月1日 A 108695 0 0 $0
Hubert James Williams 董事 2026年3月1日 A 211863 0 0 $0
Joseph Arthur Hastings 董事 2026年3月1日 A 0 0 0 $0
Elizabeth T Hirsch 董事 2026年3月1日 A 162059 0 0 $0
James S. Ely III 董事 2026年3月1日 A 412876 0 0 $0
John A Fry 董事 2026年3月1日 A 268966 0 0 $0
John A Clerico 董事 2026年3月1日 A 368763 0 0 $0
Michael Dinkins 董事 2026年3月1日 A 225882 0 0 $0
Wayne T Smith 董事 2026年3月1日 A 5217579 0 0 $0
Julia B North 董事 2021年3月1日 A 162056 0 0 $0
Mitchell H Watson JR 董事 2017年5月16日 M 22594 0 0 $0
Harvey Klein MD 董事 2010年3月15日 M 10383 0 0 $0
Dale F Frey 董事 2008年3月31日 A 20000 0 0 $0
Thomas H Lister 董事 2004年9月21日 S 0 0 0 $0
Thodore Forstmann 董事 2004年9月21日 S 0 0 0 $0
Sandra Horbach 董事 2004年9月21日 S 0 0 0 $0
Robert J Dole 董事 2004年5月6日 S 0 0 0 $0
FLC XXIX PARTNERSHIP LP 10% 所有者 2004年9月21日 S 0 0 0 $0
FLC XXX PARTNERSHIP LP 10% 所有者 2004年9月21日 S 0 0 0 $0
Winston Hutchins 10% 所有者 2004年9月21日 S 0 0 0 $0
FORSTMANN LITTLE & CO SUB DEBT & EQU MGMT BUYOUT PART VI LP 10% 所有者 2004年9月21日 S 0 0 0 $0
FORSTMANN LITTLE & CO EQUITY PARTNERSHIP V L P 10% 所有者 2004年9月21日 S 0 0 0 $0
Benjamin C Fordham · 2021年3月1日 A 254608 0 0 $0

来自SEC表格3/4/5申报的内部人士;净额=仅公开市场买卖

ETF持仓 由 25 只交易所交易基金持有

20

权重仅反映直接股权持仓(N-PORT);杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。

基金 权重 单位 截至 来源
BSJR · Invesco Exchange-Traded Self-Inde... 2.85% 24817000 2026年10月2日 每日
EBIT · Harbor ETF Trust 0.45% 19210 NS 2026年7月31日 N-PORT
IWC · iShares Trust 0.09% 443690 SH 2026年9月11日 每日
IHF · iShares Trust 0.05% 223947 SH 2026年9月11日 每日
VTWV · VANGUARD SCOTTSDALE FUNDS 0.03% 113109 SH 2026年8月19日 每日
NEAR · iShares U.S. ETF Trust 0.03% 1340000 SH 2026年9月11日 每日
PRFZ · Invesco Exchange-Traded Fund Trust 0.02% 221871 SH 2026年10月2日 每日
IWM · iShares Trust 0.01% 3425206 SH 2026年9月11日 每日
RSSL · Global X Funds 0.01% 62038 NS 2026年7月31日 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0.01% 746733 SH 2026年8月19日 每日
VHT · VANGUARD WORLD FUND 0.01% 349881 SH 2026年8月19日 每日
DFAS · Dimensional ETF Trust 0.01% 289348 NS 2026年7月31日 N-PORT
DFAC · Dimensional ETF Trust 0.00% 202789 NS 2026年7月31日 N-PORT
DFAU · Dimensional ETF Trust 0.00% 33838 NS 2026年7月31日 N-PORT
ITOT · iShares Trust 0.00% 203848 SH 2026年9月11日 每日
IWV · iShares Trust 0.00% 42177 SH 2026年9月3日 每日
DCOR · Dimensional ETF Trust 0.00% 6184 NS 2026年7月31日 N-PORT
DFUS · Dimensional ETF Trust 0.00% 31135 NS 2026年7月31日 N-PORT
VXF · VANGUARD INDEX FUNDS 0.00% 1347195 SH 2026年8月19日 每日
VTI · VANGUARD INDEX FUNDS 0.00% 3813888 SH 2026年8月19日 每日
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 9817 SH 2026年8月19日 每日
DFSU · Dimensional ETF Trust 0.00% 24 NS 2026年7月31日 N-PORT
VGHY · VANGUARD FIXED INCOME SECURITIES ... · · 2026年7月15日 每日
VPLS · VANGUARD MALVERN FUNDS · · 2026年7月15日 每日
IWN · iShares Trust · 1223127 SH 2026年9月11日 每日

CYH 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间

21
评级 · 16 位分析师 持有
中位数目标 $3.12 +14.9%
1 6.2% 强烈买入
1 6.2% 买入
6 37.5% 持有
7 43.8% 卖出
1 6.2% 强烈卖出

12个月价格目标

8 位分析师 · 2026-10-01

平均目标 $3.16 +16.0%

现在 当前价格 $2.72
最低$2.00 平均值$3.16 最高$4.00

同行比较(GICS 子行业) 关键指标与行业同行对比

22

财年依据,价格截至各公司上一个财年末收盘价。

股票代码 市值 P/E 营收同比增长 净利润率 ROE 毛利率
CYH $433M 0.8 -1.2% 4.1% -30.8% ·
SGRY $2.00B -25.3 6.2% -2.4% -4.5% ·
NUTX $1.17B 15.7 82.4% 8.1% 30.6% 50.8%
ARDT $1.26B 9.2 6.0% 2.1% 11.2% ·
USPH · 55.0 16.3% 5.1% 8.2% 19.2%
STLN · · · · · ·
JYNT $123M 45.9 5.2% 5.3% 16.3% ·
HCA $104.86B 16.5 7.1% 9.0% -159.1% ·

最新新闻 提及该公司的近期头条新闻

23

我的指标 您的个人关注列表 — 来自完整基本面的选定行

26

选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。

您的选择已保存,并会跟随您浏览所有股票。

来源:SEC 10-Q 于 七月 23, 2026 申报